DUBLIN, January 13, 2014 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/j3nzxd/contraceptives) has announced the addition of the "Global Contraceptives Market Report 2013: Forecasts to 2018" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The global contraceptive devices market held majority of the market share in 2011 on account of its high usage rates in the European and Asian regions. Contraceptive devices such as copper IUDs, male condoms and cheap subdermal contraceptive implants such as Sino-implants are some of the products responsible for the high market share.
In addition, the market share is expected to increase during the forecast period owing to the introduction of cheap and generic contraceptive drugs and the possible introduction of new and technologically advanced products such as Agile Therapeutics' AG200-15, a contraceptive patch currently in pipeline. The new contraceptive patch is currently undergoing phase III clinical trials and is expected to be launched in 2014.
The global contraceptives market can be analyzed by segmenting the market into four regions namely: North America, Asia-Pacific, Europe and rest of the world (RoW). The Asia-Pacific contraceptives market is the fastest growing segment due to the rapid economic growth of countries such as India and China.
The presence of cheap generic contraceptive pills and devices such as male condoms, copper IUDs and Sino-implants (II) (subdermal contraceptive implant) serves the Asia-Pacific contraceptives market as prominent drivers. Moreover, the presence of a huge population base and high prevalence of sexually transmitted diseases especially in South-East Asian countries have encouraged users to opt for STD-preventing contraceptives such as condoms and has expedited the growth of the Asia-Pacific contraceptives market.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Global Contraceptives Market, by Products
5 Global Contraceptives Market, by Geography
7 Company Profiles
- Agile Therapeutics Inc.
- Bayer HealthCare AG
- BioSante Pharmaceuticals Inc.
- Church & Dwight, Co. Inc.
- Mayer Laboratories, Inc.
- Merck & Co.
- Pantarhei Bioscience B.V.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Warner Chilcott Company, Inc.
For more information visit http://www.researchandmarkets.com/research/j3nzxd/contraceptives
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets